http://rdf.ncbi.nlm.nih.gov/pubchem/reference/3168454

Outgoing Links

Predicate Object
contentType Clinical Trial, Phase III|Journal Article|Randomized Controlled Trial|Research Support, Non-U.S. Gov't
endingPage 236
issn 0920-1211
issueIdentifier 1-2
pageRange 230-236
publicationName Epilepsy Research
startingPage 230
hasFundingAgency http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_2897889ea18249f8d56e85c26d8bc7d4
bibliographicCitation French JA, Cabrera J, Emir B, Whalen E, Lu F. Designing a new proof-of-principle trial for treatment of partial seizures to demonstrate efficacy with minimal sample size and duration-a case study. Epilepsy Res. 2013 Sep;106(1-2):230–6. doi: 10.1016/j.eplepsyres.2013.04.008. PMID: 23727190.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6ba7c8a2c69050a1096ebde093ae38a9
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_49cf9e1f8001bcbbcc8df04d37ef290e
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0e72b79e47b4417a5c2904a36fbb7988
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2c4d0b81ff92bd62d27610c357cf5c94
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e48f5fd305f5b7676500d3a36dd2a716
date 201309
identifier https://doi.org/10.1016/j.eplepsyres.2013.04.008
https://pubmed.ncbi.nlm.nih.gov/23727190
isPartOf https://portal.issn.org/resource/ISSN/0920-1211
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/3587
language English
source https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/
title Designing a new proof-of-principle trial for treatment of partial seizures to demonstrate efficacy with minimal sample size and duration—A case study
discusses http://id.nlm.nih.gov/mesh/M0001382
http://id.nlm.nih.gov/mesh/M0214473
http://id.nlm.nih.gov/mesh/M0008927
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D000927Q000627
http://id.nlm.nih.gov/mesh/D005680Q000031
http://id.nlm.nih.gov/mesh/D012107
http://id.nlm.nih.gov/mesh/D004828Q000188
hasSubjectTerm http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D016208
http://id.nlm.nih.gov/mesh/D008875
http://id.nlm.nih.gov/mesh/D016017
http://id.nlm.nih.gov/mesh/D000368
http://id.nlm.nih.gov/mesh/D012640Q000517
http://id.nlm.nih.gov/mesh/D017326
http://id.nlm.nih.gov/mesh/D008297
http://id.nlm.nih.gov/mesh/D005680Q000627
http://id.nlm.nih.gov/mesh/D005260
http://id.nlm.nih.gov/mesh/D000293
http://id.nlm.nih.gov/mesh/D018401
http://id.nlm.nih.gov/mesh/D000069583
http://id.nlm.nih.gov/mesh/D055815
http://id.nlm.nih.gov/mesh/D004311
http://id.nlm.nih.gov/mesh/D016896
http://id.nlm.nih.gov/mesh/D016032
http://id.nlm.nih.gov/mesh/D004359
http://id.nlm.nih.gov/mesh/D000328
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9191
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5486971

Total number of triples: 51.